Pluri Inc. (NASDAQ:PLUR) Short Interest Up 273.9% in October

Pluri Inc. (NASDAQ:PLUR) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 8,600 shares, an increase of 273.9% from the October 15th total of 2,300 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 16,000 shares, the days-to-cover ratio is presently 0.5 days.

Pluri Price Performance

NASDAQ:PLUR traded up $0.43 on Tuesday, reaching $5.53. 215,603 shares of the company’s stock traded hands, compared to its average volume of 17,449. The company has a quick ratio of 6.98, a current ratio of 6.98 and a debt-to-equity ratio of 4.44. The stock has a 50-day simple moving average of $5.08 and a 200-day simple moving average of $5.44. The firm has a market cap of $30.25 million, a PE ratio of -0.96 and a beta of 1.62. Pluri has a 12 month low of $3.77 and a 12 month high of $8.48.

Pluri (NASDAQ:PLUR) last issued its quarterly earnings data on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. The firm had revenue of $0.26 million for the quarter. Pluri had a negative net margin of 6,341.03% and a negative return on equity of 493.74%.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.